Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-23-003709
Filing Date
2023-04-13
Accepted
2023-04-13 13:40:05
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27642
2 filename2.txt TEXT-EXTRACT 1496
  Complete submission text file 0000000000-23-003709.txt   40319
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Avalo Therapeutics, Inc. (Filed for) CIK: 0001534120 (see all company filings)

EIN.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations